バイオ外科手術の世界市場2021-2028

◆英語タイトル:GLOBAL BIOSURGERY MARKET FORECAST 2021-2028
◆商品コード:INK21JU006
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2021年6月20日
◆ページ数:217
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートはバイオ外科手術の世界市場について調査・分析し、調査範囲/手法、エグゼクティブサマリー、市場動向、主要分析、製品別(止血剤、骨移植代替物、手術用シーリング剤、軟部組織管理、抗接着剤、その他)分析、ソース別(天然、合成)分析、用途別(整形手術、心臓胸部手術、神経・脊椎手術、一般手術、その他)分析、地域別分析、競争状況などを掲載したものです。
・調査範囲/手法
・エグゼクティブサマリー
・市場動向
・主要分析
・バイオ外科手術の世界市場規模:製品別(止血剤、骨移植代替物、手術用シーリング剤、軟部組織管理、抗接着剤、その他)
・バイオ外科手術の世界市場規模:ソース別(天然、合成)
・バイオ外科手術の世界市場規模:用途別(整形手術、心臓胸部手術、神経・脊椎手術、一般手術、その他)
・地域別分析
・競争状況
【レポートの概要】

KEY FINDINGS
The global biosurgery market is forecasted to record a CAGR of 6.32% during the projected period of 2021 to 2028. The market growth is attributed to the rising geriatric population, the incidence of musculoskeletal disorders, technological advancements, and the increasing research and development endeavors.
MARKET INSIGHTS
Biosurgical products are characterized as innovative solutions used to treat complex surgical conditions, provide wound sealing, and prevent excessive blood loss. These include anti-adhesive agents, surgical sealants, hemostatic agents, bone-graft substitutes, as well as soft tissue management (mesh/patch) products.
As per the data issued by the World Population Prospects: the 2019 Revision, by 2050, 1 in 6 people globally will be over the age of 65 years (16%), indicating an increase from 1 in 11 in 2019 (9%). The surge in the elderly populace has resulted in increased chronic diseases, such as cardiovascular and neurological conditions. For instance, according to the Health Union data, Parkinson’s disease is the second most common age-related nerve degenerating disorder following Alzheimer’s. The disease affects 5% of the population over age 85 years and 1% of the population over the age of 60 years. With brain grafting considered the most commonly adopted treatment procedure for Parkinson’s, the increasing geriatric population is set to propel the demand for this treatment procedure.
REGIONAL INSIGHTS
The global biosurgery market growth assessment entails the analysis of North America, the Asia-Pacific, Europe, and the Rest of World. North America held the highest market share in 2020, owing to key drivers like the rapid acceptance of technological advancements, the aging population, the growing incidence of chronic diseases, including cardiovascular ailments and cancer, and increasing government funding and investment.
COMPETITIVE INSIGHTS
The industrial rivalry within the global biosurgery market is anticipated to be moderate over the forecast years. With a fairly limited number of players, the market’s overall growth is not highly lucrative. Also, biological products must surpass stringent regulatory pathways. Hence, the competition among existing firms is moderate.
Some of the key companies operating in the market are Medtronic PLC, Becton, Dickinson and Company, Sanofi, Baxter International Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. PREVALENCE OF GERIATRIC POPULATION
3.1.2. ADVANCEMENTS IN TECHNOLOGY
3.1.3. INCIDENCE OF MUSCULOSKELETAL DISORDERS
3.1.4. SURGE IN RESEARCH AND DEVELOPMENT
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF SURGERIES
3.2.2. RISK ASSOCIATED WITH IMMUNE RESPONSE
3.2.3. GROWING POPULARITY OF MINIMALLY INVASIVE PROCEDURES
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BIOSURGERY MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. KEY BUYING CRITERIA
4.5. KEY INSIGHTS
4.6. OPPORTUNITY MATRIX
4.7. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. HEMOSTATIC AGENTS
5.2. BONE-GRAFT SUBSTITUTES
5.2.1. SYNTHETIC GRAFT EXTENDERS
5.2.2. DEMINERALIZED BONE MATRIX
5.2.3. BONE MORPHOGENETIC PROTEINS
5.2.4. CELL-BASED MATRICES
5.3. SURGICAL SEALING AGENTS
5.3.1. NATURAL
5.3.2. SYNTHETIC
5.4. SOFT-TISSUE MANAGEMENT
5.4.1. SYNTHETIC MESH/PATCH
5.4.2. NATURAL MESH/PATCH
5.5. ANTI-ADHESIVE AGENTS
5.6. STAPLE LINE REINFORCEMENT
6. MARKET BY SOURCE TYPE
6.1. NATURAL
6.2. SYNTHETIC
7. MARKET BY APPLICATION
7.1. ORTHOPEDIC SURGERY
7.2. CARDIO AND THORACIC SURGERY
7.3. NEURO AND SPINE SURGERY
7.4. GENERAL SURGERY
7.5. OTHER APPLICATIONS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.2. CANADA
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. KEY GROWTH ENABLERS
8.2.3. KEY CHALLENGES
8.2.4. KEY PLAYERS
8.2.5. COUNTRY ANALYSIS
8.2.5.1. GERMANY
8.2.5.2. UNITED KINGDOM
8.2.5.3. FRANCE
8.2.5.4. ITALY
8.2.5.5. RUSSIA
8.2.5.6. BELGIUM
8.2.5.7. POLAND
8.2.5.8. REST OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. KEY GROWTH ENABLERS
8.3.3. KEY CHALLENGES
8.3.4. KEY PLAYERS
8.3.5. COUNTRY ANALYSIS
8.3.5.1. CHINA
8.3.5.2. JAPAN
8.3.5.3. INDIA
8.3.5.4. AUSTRALIA & NEW ZEALAND
8.3.5.5. SOUTH KOREA
8.3.5.6. THAILAND
8.3.5.7. INDONESIA
8.3.5.8. VIETNAM
8.3.5.9. REST OF ASIA-PACIFIC
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. KEY GROWTH ENABLERS
8.4.3. KEY CHALLENGES
8.4.4. KEY PLAYERS
8.4.5. REGIONAL ANALYSIS
8.4.5.1. LATIN AMERICA
8.4.5.2. MIDDLE EAST & AFRICA
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. BAXTER INTERNATIONAL INC
9.2.2. B BRAUN MELSUNGEN AG
9.2.3. BECTON, DICKINSON AND COMPANY (C R BARD)
9.2.4. BETATECH MEDICAL
9.2.5. CSL LIMITED
9.2.6. CRYOLIFE INC
9.2.7. ETHICON INC (JOHNSON & JOHNSON)
9.2.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9.2.9. MEDTRONIC PLC
9.2.10. RTI SURGICAL
9.2.11. SANOFI
9.2.12. SMITH & NEPHEW PLC
9.2.13. STRYKER CORPORATION
9.2.14. WRIGHT MEDICAL GROUP NV
9.2.15. ZIMMER BIOMET HOLDINGS INC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - BIOSURGERY
TABLE 2: AGING POPULATION AROUND THE WORLD 2019 & 2050
TABLE 3: GLOBAL BIOSURGERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 4: GLOBAL BIOSURGERY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 5: GLOBAL HEMOSTATIC AGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 6: GLOBAL HEMOSTATIC AGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 7: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 8: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 10: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL SYNTHETIC GRAFT EXTENDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 12: GLOBAL SYNTHETIC GRAFT EXTENDERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 13: GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 14: GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 15: GLOBAL BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 16: GLOBAL BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 17: GLOBAL CELL-BASED MATRICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 18: GLOBAL CELL-BASED MATRICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 19: GLOBAL SURGICAL SEALING AGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 20: GLOBAL SURGICAL SEALING AGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 21: GLOBAL SURGICAL SEALING AGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 22: GLOBAL SURGICAL SEALING AGENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 23: GLOBAL NATURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 24: GLOBAL NATURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 25: GLOBAL SYNTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 26: GLOBAL SYNTHETIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 27: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 28: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 29: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 30: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 31: GLOBAL SYNTHETIC MESH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 32: GLOBAL SYNTHETIC MESH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 33: GLOBAL NATURAL MESH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 34: GLOBAL NATURAL MESH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 35: GLOBAL ANTI-ADHESIVE AGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 36: GLOBAL ANTI-ADHESIVE AGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 37: GLOBAL STAPLE LINE REINFORCEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 38: GLOBAL STAPLE LINE REINFORCEMENT MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 39: GLOBAL BIOSURGERY MARKET, BY SOURCE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 40: GLOBAL BIOSURGERY MARKET, BY SOURCE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 41: GLOBAL NATURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 42: GLOBAL NATURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 43: GLOBAL SYNTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 44: GLOBAL SYNTHETIC MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 45: GLOBAL BIOSURGERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 46: GLOBAL BIOSURGERY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 47: GLOBAL ORTHOPEDIC SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 48: GLOBAL ORTHOPEDIC SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 49: GLOBAL CARDIO AND THORACIC SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 50: GLOBAL CARDIO AND THORACIC SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 51: GLOBAL NEURO AND SPINE SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 52: GLOBAL NEURO AND SPINE SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 53: GLOBAL GENERAL SURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 54: GLOBAL GENERAL SURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 55: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 56: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 57: GLOBAL BIOSURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 58: GLOBAL BIOSURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 59: NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 60: NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 61: LEADING PLAYERS OPERATING IN NORTH AMERICA BIOSURGERY MARKET
TABLE 62: EUROPE BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 63: EUROPE BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 64: LEADING PLAYERS OPERATING IN EUROPE BIOSURGERY MARKET
TABLE 65: ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 66: ASIA-PACIFIC BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 67: LEADING PLAYERS OPERATING IN THE ASIA-PACIFIC BIOSURGERY MARKET
TABLE 68: REST OF WORLD BIOSURGERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 69: REST OF WORLD BIOSURGERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 70: LEADING PLAYERS OPERATING IN REST OF WORLD BIOSURGERY MARKET
TABLE 71: LIST OF MERGERS & ACQUISITIONS
TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 73: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 74: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES


LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: GLOBAL BIOSURGERY MARKET, BY PRODUCT, IN 2020
FIGURE 6: GLOBAL BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 11: GLOBAL BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 15: GLOBAL BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL BIOSURGERY MARKET, BY SOURCE TYPE, IN 2020
FIGURE 21: GLOBAL BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL BIOSURGERY MARKET, BY APPLICATION, IN 2020
FIGURE 24: GLOBAL BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 25: GLOBAL BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 26: GLOBAL BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 27: GLOBAL BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 28: GLOBAL BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 29: NORTH AMERICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 30: UNITED STATES BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 31: CANADA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 32: EUROPE BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 33: GERMANY BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 34: UNITED KINGDOM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 35: FRANCE BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 36: ITALY BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 37: RUSSIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 38: BELGIUM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 39: POLAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 40: REST OF EUROPE BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 41: ASIA-PACIFIC BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 42: CHINA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 43: JAPAN BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 44: INDIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 45: AUSTRALIA & NEW ZEALAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 46: SOUTH KOREA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 47: THAILAND BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 48: INDONESIA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 49: VIETNAM BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 50: REST OF ASIA-PACIFIC BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 51: REST OF WORLD BIOSURGERY MARKET, BY REGION, 2020 & 2028 (IN %)
FIGURE 52: LATIN AMERICA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)
FIGURE 53: MIDDLE EAST & AFRICA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[バイオ外科手術の世界市場2021-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆